Human Clinical Study Summary

 

Authors

Purpose

Finding

 Pub. Status

Lembcke et al.

Safety and

Nutrition

Safe in children with malnutrition;

Increased protein and energy retention

Published

Hanning et al.

Safety and

Nutrition

Safe in young adults;

Increased plasma amino acids

Unpub.

Begin et al.

Growth and

Morbidity

Safe for use in breast-fed infants;

Tendency for reduced days with persistent diarrhea

 Published

Earnest et al.

Blood lipids

ImmunoLin lowered total and LDL cholesterol

 Published

Weaver et al.

Morbidity

Reduced days with diarrheal symptoms

 Unpub.

Bishop et al.

Safety and

Morbidity

ImmunoLin is safe for use in ped. IBD patients

 Unpub.

 Marcos et al.

Body Weight 

Decreased involuntary weight loss 

Unpub.